NF-κB inhibitors, such as pyrrolidine dithiocarbamate and parthenolide, can eliminate the stimulation of TLR3 ligand poly (I:C) on the production of VEGF and IL-8 in RA FLS (Moon et al., 2010). This evidence concerns the gene CXCL8 and rheumatoid arthritis.